Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

Summary Background Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income countries globally, and identified factors associated with mortality. Methods We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation, and Hirschsprung’s disease. Recruitment was of consecutive patients for a minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. We did a complete case analysis. Findings We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal malformation, and 517 with Hirschsprung’s disease) from 264 hospitals (89 in high-income countries, 166 in middleincome countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male. Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3). Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups). Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in lowincome countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries; p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11], p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20 [1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention (ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed (ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65 [0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality. Interpretation Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between lowincome, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger than 5 years by 2030

Cost comparison of pressure ulcer preventive dressings: hydrocolloid dressing versus transparent polyurethane film

Objective: To evaluate and compare the costs of using a transparent polyurethane film (PF) and hydrocolloid dressing (HD) in the prevention of pressure ulcers (PUs). Method: This descriptive, observational, longitudinal, comparative study was conducted in the intensive care units, coronary care unit and medical clinic of a charity hospital in Brazil. Data were collected during a 30-day study period, consisting of physical examination, assessment of risk factors for PU development and application of the Braden scale, which were performed at inclusion in the study and once daily during hospitalisation. Either PF or HD was applied bilaterally in the sacral and trochanteric regions for prevention of PUs in patients at a moderate to high risk of PUs according to the Braden scale, and costs of using PU preventive dressings were estimated. Results: The mean total costs per dressing change per patient when using the HD and PF to prevent PUs were 413.60 BRL and 74.04 BRL, respectively. There were significant between-group differences in mean costs for all variables, except for saline solution and nurse-technician services. Conclusion: Results showed that the mean cost per dressing change per patient was lower when using the transparent PF than when using the HD. Declaration of interest: The authors state no conflict of interest.Holy House Mercy Passos, Passos, MG, BrazilUniv Vale Sapucal, Pouso Alegre, MG, BrazilIESF, MogiGuacu, SP, BrazilState Univ Minas Gerais UEMG, Passos, MG, BrazilFed Univ Alfenas UNIFAL, Alfenas, MG, BrazilUniv Fed Sao Paulo, Sao Paulo, SP, BrazilDivision of Plastic Surgery, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, BrazilWeb of Scienc

Bois-bumbás de Parintins: síntese metafórica da realidade? Bois-bumbás of Parintins: metaphoric synthesis of reality?

Este artigo analisa como os atores sociais internos percebem o evento dos bois-bumbás da cidade de Parintins, tendo em vista o valor que tal fenômeno representa para a comunidade local nos aspectos culturais, econômicos e sociais, e por criar um espaço onde os seus integrantes possam refletir, falar e produzir conhecimento sobre sua realidade. Procurou-se identificar a percepção dos atores sociais internos sobre a influência desse fenômeno cultural nas dimensões sistêmica e cultural do desenvolvimento local sustentável (DLS) da cidade de Parintins. Os pressupostos que orientaram o estudo foram: elementos da cultura brasileira estão presentes na cultura local representada pelo contexto dos bois-bumbás; a cultura indígena amazônica dá significado aos elementos que possibilitam a construção dos bois-bumbás; e o boi-bumbá está se transformando em mercadoria subsumida às necessidades do capital. O referencial de análise baseou-se principalmente nos conceitos de DLS, modo de produção capitalista e cultura. A metodologia utilizada foi de natureza qualitativa. As conclusões sinalizam para a confirmação dos pressupostos.<br>This article investigates on how the inside social actors perceive the boi-bumbá celebrations in the town of Parintins, Brazil, considering the value that such phenomenon represents to the local community in its cultural, economic and social aspects, as well as the opportunity for the participants to reflect on, speak about and produce knowledge on their own reality. The investigation identified how such actors perceive the influence of this social phenomenon in the systemic and cultural dimensions of the town's sustainable local development (SLD). The hypotheses that guided the study were: elements of the Brazilian culture are present in the local culture represented by the boi-bumbá context; the native Amazonian culture gives signification to the elements that allow the construction of the bois-bumbás; the boi-bumbá is becoming a merchandise submitted to the capital's demands. The analytical framework was based mostly in the concepts of SLD, capitalist production system and culture. The investigation adopted a quantitative method. The conclusions confirm the hypotheses

International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module

We report the results of an International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2007-December 2012 in 503 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe. During the 6-year study using the Centers for Disease Control and Prevention's (CDC) U.S. National Healthcare Safety Network (NHSN) definitions for device-associated health care–associated infection (DA-HAI), we collected prospective data from 605,310 patients hospitalized in the INICC's ICUs for an aggregate of 3,338,396 days. Although device utilization in the INICC's ICUs was similar to that reported from ICUs in the U.S. in the CDC's NHSN, rates of device-associated nosocomial infection were higher in the ICUs of the INICC hospitals: the pooled rate of central line–associated bloodstream infection in the INICC's ICUs, 4.9 per 1,000 central line days, is nearly 5-fold higher than the 0.9 per 1,000 central line days reported from comparable U.S. ICUs. The overall rate of ventilator-associated pneumonia was also higher (16.8 vs 1.1 per 1,000 ventilator days) as was the rate of catheter-associated urinary tract infection (5.5 vs 1.3 per 1,000 catheter days). Frequencies of resistance of Pseudomonas isolates to amikacin (42.8% vs 10%) and imipenem (42.4% vs 26.1%) and Klebsiella pneumoniae isolates to ceftazidime (71.2% vs 28.8%) and imipenem (19.6% vs 12.8%) were also higher in the INICC's ICUs compared with the ICUs of the CDC's NHSN